INTRODUCTION
Enterovirus A71 (EV-A71), a typical positive single-stranded RNA virus, was first identified in 1969 in patients with central nervous system disease (Manki et al., 1997; Schmidt et al., 1974) . EV-A71 belongs to the Picornaviridae family of viruses, with a genome of nearly 7.4 kb encoding four structural proteins (VP1, VP2, VP3, and VP4) and seven non-structural proteins (2A, 2B, 2C, 3A, 3B, 3C, and 3D) (Lin et al., 2009a; . EV-A71 has also been recognized as an agent for hand-foot-and-mouth disease (HFMD). HFMD is usually a mild and self-limiting disease; however, sometimes it causes severe neurological disorders or even death due to the limited effective treatment for EV-A71 infection (Hamaguchi et al., 2008; . Furthermore, EV-A71 has shown repeated outbreaks worldwide in the last decade and infects millions of people annually .
It is well known that the initiation of EV-A71 protein translation the first step for initiating viral replication after entry into host cells is driven by the internal ribosome entry site (IRES) in the 5 0 UTR. This occurs in a cap-independent manner and is regulated by many positive and negative regulators (Lee et al., 2017) . EV-A71 contains a type I IRES with five stem loops (domains II-VI), which binds to the cleaved eukaryotic initiation factor eIF4G (Thompson and Sarnow, 2003) . The viral translation process is highly promoted by viral protein 2A protease (2A pro ). The protein 2A pro cleaves eIF4G, and then the cleaved eIF4G binds and enhances viral IRES activity (Glaser and Skern, 2000) . Although a number of IRES trans-acting factors (ITAFs), such as AU-rich element-binding factor 1 (AUF1) , upstream element-binding protein (FBP) 1-3 (Huang et al., 2011) , hnRNP K (Lin et al., 2008) , and hnRNP A1 (Lin et al., 2009b) have been identified, current knowledge on their regulation is very limited.
Previous studies have uncovered several host factors required for EV-A71 replication. For example, the virus first attaches to the cell membrane factors heparan sulfate glycosaminoglycans (Tan et al., 2013) and PSGL1 (Nishimura et al., 2009) . It then releases the viral genome for the production of viral components helped by host factors such as AUF1 , FBP1 (Huang et al., 2011) , and hnRNP A1 (Lin et al., 2009b) and is subsequently assembled for the release of the virus from cells. It has been shown that some pan protein kinases, such as phosphatidylinositol 3-kinase and MERK/ERK kinases, play crucial roles in EV-A71 replication (Duan et al., 2017; Hung et al., 2014; Wang et al., 2017; Wong et al., 2005) . The inhibitors of these kinases potently inhibited viral replication (Sun et al., 2016; Zhang et al., 2018) . However, results from anticancer clinical studies of these inhibitors showed strong side effects. It would be a great idea to target a specific kinase to treat cancers and viral infections.
Pim1, a member of the calmodulin-dependent protein kinase family together with another two kinases, is a serine-threonine kinase identified as the preferential site of integration for the Moloney murine leukemia virus (Selten et al., 1985) . Pim1 is elevated and plays crucial roles in several types of human cancers such as prostate adenocarcinoma, mantle cell lymphomas, and hematopoietic malignancies (Nawijn et al., 2011) . Recently, several groups reported that Pim1 affects viral transcription activation and modulates the latency and productive infections (De Vries et al., 2015; Park et al., 2015; Vries et al., 2016) . However, to date there have been no reports that show any response or effect of Pim1 in EV-A71 replication. Therefore, in this study, we analyzed the expression profile of Pim1 after EV-A71 infection. We showed that Pim1 was upregulated in response to EV-A71 infection. More importantly, we not only demonstrated the importance of Pim1 in EV-A71 infection but also revealed the potent antiviral effects of Pim1 inhibitors, potential agents for antiviral treatment as well.
RESULTS

Stimulation of Pim1 mRNA Level by EV-A71 Infection
To reveal the regulation pattern of Pim1 in EV-A71 infection, the mRNA level of Pim1 was analyzed during the process of viral infection. RD cells were infected with EV-A71 or inactive EV-A71 (UV light-inactive virus) at MOI of 1 and 10, and cellular mRNA was extracted at different time points (post infection, p.i.). The results showed that the mRNA level of Pim1 notably increased as early as 3 h p.i. at a high MOI of 10, and significant upregulation was observed at 6 and 9 h p.i. both at MOIs 1 and 10, when compared with the control group ( Figure 1A) . Notably, although virus treated with UV would not affect virus entry (Dong et al., 2018; , it did not stimulate Pim1 response.
Inhibition of EV-A71 Replication by Knockdown of Pim1
To determine whether Pim1 was required during EV-A71 infection, an RNAi approach was employed to knockdown the level of Pim1; 48 h after small interfering RNA (siRNA) transfection, the level of Pim1 mRNA was reduced in RD and HeLa cells by 80% and 70% by siPim1-1-and siPim1-2-specific siRNAs, respectively, when compared with non-targeting sequences, as quantified by qRT-PCR (p < 0.01) (Figures 1B and 1D) . MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assays were performed to determine cell viability upon Pim1 silencing. There was no significant difference in cell number between siPim1-transfected cells and non-target RNA-transfected cells at 24 and 48 h post transfection (data not shown).
RD or HeLa cells were transfected with siPim1-1-or siPim1-2-specific siRNA at 40 nM or non-target siRNA as control. After 24-h transfection, cells were infected with EV-A71 at an MOI of 0.01. As shown in Figures 1C and 1E, extracellular virion RNA levels were strongly decreased in Pim1-specific siRNA-treated cells when compared with cells treated with non-targeting sequences (p < 0.01). The viral titer was also determined after silencing Pim1. The results showed that the viral titer was significantly decreased in both RD and HeLa cells after knockdown of Pim1 ( Figures 1F and 1G ). Knockdown of Pim1 protected the cytopathic effects induced from EV-A71 infection in RD cells ( Figure 1H ). The viral protein (VP1) expression level was determined in both RD and HeLa cells. Results showed that VP1 was significantly decreased in both RD and HeLa cells after silencing Pim1 ( Figures 1I-1L ).
Promoting EV-A71 Replication by Ectopic Expression of Pim1
To further validate the function of Pim1 on virus replication, we conducted gain-of-function studies by ectopic expression of Pim1 by transfection of a Pim1-expressing plasmid into both RD and HeLa cells. We showed that ectopic expression of Pim1 increased viral titers both in RD and HeLa cells (Figures 2A  and 2B ). The viral VP1 protein level also significantly increased in the cells with ectopic expression of Pim1 ( Figures 2C-2F ). Furthermore, we performed a rescue experiment to show the function of Pim1 in EV-A71 infection. We first knocked down the endogenous Pim1 expression by an siRNA that specifically targets the 3 0 UTR in RD cells, ectopically expressed Pim1 (resistance to siRNA) with a plasmid for 48 h, and then infected with EV-A71 at MOI = 1 for 24 h. Our results showed that the reduced VP1 level by Pim1 depletion was restored by the ectopic Pim1 expression, excluding the possibility that the VP1 decrease by siRNA is due to off-target effects (Figures 2G and 2H) .
Enhancing Viral IRES Activity by Pim1
It is well known that enterovirus protein translation is initiated through viral IRES elements in a cap-independent manner. A dicistronic reporter plasmid was used to evaluate EV-A71 IRES activity when Pim1 was of Pim1 increased the EV-A71 IRES activity to 200% of the control, whereas knockdown of endogenous Pim1 expression decreases EV-A71 IRES activity to 40% of the control. We later co-transfected pIRES and a viral protein-expressing plasmid individually. Our results showed that viral 2A pro was the most effective protein that increased the IRES activity ( Figure 3D ). After we transfected all viral protein expression plasmids into 293T cells, we found that viral 2A pro as well as VP4, 2B, and 3B stimulated Pim1 expression, whereas only 2A pro significantly increased the mRNA level of Pim1 by more than two times ( Figure 3E ). To further address our findings, we then performed the rescue experiments. We silenced Pim1 and then ectopically expressed 2A pro . We demonstrated that 2A pro rescued the reduction of IRES activity after knockdown of Pim1 ( Figure 3F ).
Suppression of EV-A71 Infection by Pim1 Inhibitors
Highly selective Pim1 inhibitors have been developed for anti-tumor activity in the past decade. CX-6258
methylene]-2,4-thiazolidinedione) are novel, orally bioavailable inhibitors for treating patients with cancer in clinical trials (Haddach et al., 2012; Chen et al., 2009; Harada et al., 2015) . To further test whether Pim1 could be a potential drug target against EV-A71 infection, we examined the effects of these inhibitors on EV-A71 infection in both RD and HeLa cells. We first tested all the inhibitors on cell viability in 293T, RD, and HeLa cells by MTT assay. Our results showed that SGI-1776 and CX-6258 inhibited cell growth at a higher concentration, whereas AZD-1208 did not affect cell growth ( Figure S1 ). We pretreated RD or HeLa cells for 2 h with indicated inhibitors and concentrations and then infected with EV-A71 for 24 h at MOI 1. As shown in Figures 4A-4L , the VP1 expression level was remarkably repressed by Pim1 inhibitors in a dose-dependent manner. CX-6258 showed the best inhibitory effects in RD cells ( Figures 4A and 4G) . We further used CX-6258 as a Pim1 inhibitor to determine the extracellular viral mRNA levels, as mentioned above. The results showed that after inhibiting Pim1, viral mRNA levels were significantly decreased both in RD and HeLa cells ( Figures 4M and 4N ). In addition, the viral titer was also decreased by more than 10 3 after inhibiting Pim1 activity with CX-6258 in RD and HeLa cells ( Figures 4O and 4P ).
Inhibition of 2A pro -Mediated eIF4G Cleavage by Inhibition of Pim1
To address how Pim1 affects the IRES activity regulated by 2A pro , we checked the effect of Pim1 on 2A pro cleavage activity. We and others previously reported that the IRES-driven translation was activated after the cleavage of eIF4G by 2A pro Dong et al., 2018; . We first tested whether Pim1 inhibitors could affect the cleavage of eIF4G after virus infection. As shown in Figures 5A and 5B , RD cells were treated with CX-6258 at different concentrations and then infected with EV-A71 at MOI 10. After 9 h p.i., the cleavage of eIF4G was significantly inhibited. We confirmed the expression plasmid 2A pro cleavage activity in 293T cells ( Figures 5C and 5E ). To further demonstrate the underlying mechanism, HEK293T cells were first treated with CX-6258 for 2 h and then co-transfected with a 2A pro -expressing plasmid for 36 h. We found that the cleavage of eIF4G was also inhibited with Pim1 inhibitor in a dose-dependent manner (Figures 5G and 5H) . Similarly, when 293T cells were transfected with the Pim1 expression plasmid for 48 h, and then infected with EV-A71 at MOI 10 for the indicated time points, the cleavage of eIF4G was upregulated in the Pim1 ectopically expressed cells ( Figures 5D and 5F ). To test whether the Pim1 inhibitor would directly affect 2A pro activity, we further examined the status of 2A pro -mediated eIF4G cleavage in Pim1 knockdown cells treated with CX-6258 at different concentrations (1, 2, and 4 mM) . Our results showed that CX-6258 did not further affect 2A pro activity in the Pim1-depleted cells ( Figures 5I and 5J) , demonstrating that the inhibitory effects of 2A pro -mediated eIF4G cleavage were mediated through the suppressed Pim1 kinase activity.
Induction of the Cytoplasmic Accumulation of AUF1 by Inhibition of Pim1
We further explored whether other mechanism(s) of Pim1 are involved in the regulation of the viral IRES activity. After treating cells with the Pim1 inhibitor CX-6258 for 2 h without viral infection or 2A expression, we isolated the cytoplasm and nuclear proteins and applied western blot assays. After examining the translocation of ITAF factors, including AUF1, hnRNP K, FBP1, and Sam68, we found that only AUF1, a suppressor of the IRES, was affected by the Pim1 inhibitor. The accumulation of AUF1 in the cytoplasm was significantly increased (Figures 6A and 6B) . Consistently, only AUF1, but not hnRNP K, FBP1, or Sam68, translocated from the nucleus to the cytosol after knockdown of Pim1 by target-specific siRNA ( Figures  6C and 6D ). We also used confocal images to examine the cellular localization of AUF1. AUF1 accumulation was shown in the cytoplasm in the cells treated with the Pim1 inhibitor ( Figure 6E ). We also noticed that AUF1 appeared to form puncta in the cytoplasm at 2 and 4 mM concentrations of CX-6258, which correlated with the stress response of Pim1 and AUF1 (Braso-Maristany et al., 2016; Roggli et al., 2012) .
DISCUSSION
In this study, we have provided evidence that Pim1 is a positive regulator for EV-A71 replication. Pim1 elevated EV-A71 replication by upregulating IRES activity by increasing 2A pro -mediated eIF4G cleavage and blocking AUF1 translocation from the nucleus to the cytosol. More importantly, we discovered that Pim1 inhibitors potently repressed EV-A71 infection. Particularly, CX-6258 reduced the viral titer over 1,000 times, a strong indication as a potential antiviral drug against enterovirus infections.
Previously, different expression patterns were observed, and many novel host genes regulated by EV-A71 infection have been identified, including those involved in the immune response, endoplasmic reticulum stress, and vesicular trafficking. In 2004, Shih et al. observed the upregulation of apoptotic genes in response to EV-A71 infection by analyzing 10,692 gene profiles in infected human SF268 cells (Shih et al., 2004) . In addition, Leong et al. found that there is a trend to inhibit cell apoptosis and cell growth arrest by analyzing 7,600 genes in EV-A71 (strain MS/7423/87, B2 sub-genotype)-infected RD cells (Leong and Chow, 2006) . In 2011, Kan et al. used RNAi screening and identified 256 host factors involved in EV-A71 replication in RD cells . However, the function and importance of these host factors in EV-A71 replication are largely unclear. In our previous studies, we demonstrated that several heat shock proteins, including ERp57, Hsc70, and Hsp27, play a crucial role in EV-A71 infection by regulating viral IRES activities. In these studies, we showed that heat shock protein inhibitors markedly suppressed virus replication by decreasing IRES activities Dong et al., 2018; .
It was particularly interesting to find that Pim1, an important kinase involved in human cancers and never reported to be involved in the process of EV-A71 infection, was upregulated following EV-A71 infection ( Figure 1A ). We postulated that Pim1 must have played important role in EV-A71 replication because the process of virus replication often shares similar signaling cascades to those involved in cancer cell growth, migration, or cell death. By loss-and gain-of-function studies, we showed that Pim1 played crucial role in facilitating EV-A71 replication (Figures 1 and 2) . Our data demonstrated the importance of Pim1 in EV-A71 infection.
IRES plays a key role in the synthesis of viral proteins during EV-A71 infection (Gao et al., 2014) . In this study, we further demonstrated that Pim1 promoted IRES activity upon EV-A71 infection (Figure 3 ). EV-A71 infection increased Pim1 expression level (Figures 1 and 3) , and the increased Pim1 expression promoted EV-A71 replication (Figure 2 ). We then tested if Pim1 inhibitors restricted EV-A71 replication. All three Pim1-specific inhibitors (SGI-1776, CX-6258, AZD-1208) showed a high potency to suppress viral infectivity (Figure 4) . We chose the best antiviral inhibitor CX-6258 and tested its effects on both intracellular and extracellular viral RNA levels, which reflected viral replication and reproduction, respectively. We showed that both viral RNA levels and viral titer dramatically decreased in a dose-dependent manner (Figure 4) .
EV-A71 recruits many host factors to facilitate viral protein synthesis via IRES-mediated translation. We previously showed that Hsc70 binds the full length of viral RNA and promotes IRES activity. Hsc70 regulates IRES activity and serves as an antiviral target of EV-A71 infection (Dong et al., 2018) . It is interesting to test whether Pim1 kinase could enhance IRES activity in other ways. We first found that 2A pro rescued the reduced IRES activity in Pim1-silenced cells. 2A pro is one of the well-known proteases that cleaves eIF4G to promote viral replication (Glaser and Skern, 2000) . The cleaved eIF4G separates into two parts, and the C-terminal part directly binds IRES to initiate the viral translation process (Ohlmann et al., 1996) . However, it was not known if Pim1 could affect IRES activity by regulating 2A pro activity. Surprisingly, we did observe that inhibition of Pim1 by either both siRNAs or the inhibitor (CX-6258) inhibited the cleavage of eIF4G cleavage upon EV-A71 infection ( Figure 5 ). The Pim1 inhibitor suppressed 2A pro -mediated eIF4G cleavage in a dose-dependent manner ( Figure 5 ). More importantly, the Pim1 inhibitor showed no effect on 2A pro -mediated eIF4G cleavage after knockdown of Pim1, demonstrating the high specificity of the inhibitor to Pim1 kinase, instead of a possible effect on 2A protease. In addition, we revealed that Pim1 (possibly the dominant p40 isoform) played a crucial role in the control of AUF1 cytosol translocation ( Figure 6 ). In conclusion, we have demonstrated that Pim1 contributes to EV-A71 infection through two distinct mechanisms. Pim1 exhibits a positive role in EV-A71 infection by enhancing IRES activity by stimulating 2A pro -mediated eIF4G cleavage and blocking AUF1 cytosol translocation (Figure 7) . Most importantly, we provide evidence that Pim1 inhibitors, particularly CX-6258, decrease viral reproduction by over 1,000 times, providing a potent antiviral agent for potential clinical settings in the future.
Limitations of the Study
Our study has demonstrated that Pim1 exhibits a positive role in EV-A71 replication by enhancing IRES activity by two distinct mechanisms, i.e., enhancing 2A pro -mediated eIF4G cleavage and blocking AUF1 cytosol translocation. We have performed several experiments such as western blot, qRT-PCR, and mass spectrum analysis to see if there are interaction sites between these proteins. However, we failed to determine whether Pim1 directly binds eIF4G or affects eIF4G phosphorylation. The interplay between VP4, 2B, 3B, and Pim1 cannot be excluded, and further studies are required in the future. Nevertheless, as anticancer agents, Pim1 inhibitors show great antiviral activities that are very attractive for the treatment of patients with HFMD in the future.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file. Biosystems, USA), using the following program: 50°C for 2 min, 95°C for 10 min followed by 45 22 cycles of 95°C for 15s and 60°C for 1 min. Sets of primers for these genes are available upon request. 23
All samples were run in triplicate and the experiment was repeated three times. The messenger RNA 24 (mRNA) level of each target gene was normalized to the mRNA copies of GAPDH in the same 25 sample and results were expressed as a percentage of the negative control (set as 1 GUAUGAUAUGGUGUGUGGAGAUAUUC, siPim1-2-Antisense: 33 GAAUAUCUCCACACACCAUAUCAUAC) were used at 40nM to inhibit endogenous Pim1 34 expression. For the rescue assay ( Fig. 3G&3H) , siRNA was designed by targeting Pim1 3'-UTR 35 (sense: 5′-ACAUUUACAACUCAUUCCA-3′, antisense: 5′-UGGAAUGAGUUGUAAAUGU-3′) 36 (Park et al., 2015) . Scramble siRNA was used as the control purchased from GenePharma (Shanghai, 37
China). Transfection of siRNA was performed according to the manufacturer's instructions. In brief, 38 cells at 50% confluence were transfected with 40 nM siRNA using Lipofectamine 3000. 39 40 4. Plasmids construction 41 vector between BamH I and Xba I sites. The EV-A71 report plasmid pRIRESF was constructed as 44 follows: Renilla Luciferase gene (RLuc) was inserted into pcDNA4/HisMax B between BamH I and 45
EcoR V sites (Wang M et al., 2016) ; EV-A71 IRES was amplified from EV-A71 virus strain 46 (SHZH98). Also, Firefly Luciferase gene (FLuc) was amplified by using a primer which has an 47 overlapping sequence with the C-terminal of EV-A71 IRES. Finally, the IRES-FLuc constructs were 48 then amplified by using overlap PCR and inserted downstream of the Renilla Luciferase gene by 49 using EcoRV and XbarI. The control plasmid pRF was constructed in similar way except it contained 50 EV-A71 IRES upstream of the FLuc gene (Fig. 4A ). The FLuc gene was amplified and then inserted 51 downstream of the Renilla Luciferase gene by using EcoRV and XbarI. All primers used in plasmid 52 construction are available upon request. 53
Viral RNA quantification 71
EV-A71 viral RNA was determined as previously described . Briefly, the total cellular 72 RNA was isolated for intracellular viral RNA quantification. To calculate the extracellular virions, 73 the culture media of infected cells was firstly harvested and briefly centrifuged to remove cell debris. 74 Viral core particles were then precipitated with 10% polyethylene glycol 8000 containing 0.5 M NaCl 75 at 4°C overnight. After centrifuging for 30 min at 16,000 g, viral particles were pelleted and treated 76 with 100 μg/ml of RNase A (Sigma, USA). To isolate the intracellular virions, EV-A71 infected cells 77 were lysed with lysis buffer (1% Triton 100 and 1 x Roche protease inhibitor cocktail in PBS). Then 78 the cell lysates were used to isolate viral particles as described above. To set up the standard curve of 79 infectious viruses, the viral titers were first determined by a CPE assay. Then the viral RNA was 80 extracted from the infectious EV-A71 viruses. RNA was serial diluted at tenfold and used to reflect 81 the calculated PFU from 10 to 1 × 10 7 live virions. 82 83 7. Virus titration. 84
Virus titration was performed as reported in our previously manuscripts Wang et al., 85 2016) . RD cells were seeded into 96-well plates for 24 h before infection, then cells were infected by 86 100 μl per well of serial 10-fold diluted supernatant in quintuplicate. The 50 % tissue culture-infected 87 dose (TCID50) was calculated by the Reed-Muench method after 96 h of infection. 88 89
Luciferase assays 90
Luciferase assays were performed as previously described Dong et al., 2018) . 293T 91 cells were plated in 24-wells one day before transfection. Over expression of the Pim1 plasmid or 92 corresponding siRNA were transfected. Next, 24 hours later, cells were transfected with PRIF or PRF 93 reporter plasmids. Two days after first-round transfection, cell extracts were prepared in passive 94 buffer (Promega, USA) and assayed for Renilla luciferase (RLuc) and Firefly luciferase (FLuc) 
